SN-202

N/A

Report date: 2022/01/06 14:01:02
NME

Base Information

Drug NameSN-202
Drug Alias NameSN-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsSerine/threonine-protein kinase mTOR modulators
TargetsSerine/threonine-protein kinase mTORPI3-kinase class I
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan UniversitySichuan Sinovation Bio-technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan UniversitySichuan Sinovation Bio-technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A